Events & Media

PRESS RELEASES


Dec 17 09 Regado Biosciences, Inc. Completes $40 Million Series D Financing Nov 25 09 Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 Nov 12 09 Regado Biosciences to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009 Nov 11 09 Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009 Nov 10 09 Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16, 2009 Nov 03 09 Regado Biosciences to Present at the 3rd Annual Canaccord Adams Cardiovascular Conference on November 10, 2009 Oct 27 09 Regado Biosciences to Present at the BIO-Europe Conference 2009 on November 3, 2009 Oct 22 09 Regado Biosciences to Present at the 8th Annual BIO Investor Forum on October 29, 2009 Oct 05 09 Regado Biosciences to Present at the 2009 Japan Biopharma Partnering Conference on October 6, 2009 Sep 17 09 Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers Sep 15, 2009 Regado Biosciences to Present at the Biopharm America 2009 Conference on September 17, 2009 Sep 9, 2009 REGADO BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN RADAR (Phase 2b) STUDY OF REG1 ANTICOAGULATION SYSTEM Sep 4, 2009 REGADO BIOSCIENCES TO PRESENT AT THE THOMAS WEISEL PARTNERS HEALTHCARE CONFERENCE 2009 ON SEPTEMBER 11, 2009 Sep 3, 2009 REGADO BIOSCIENCES TO PRESENT AT THE RODMAN & RENSHAW GLOBAL INVESTMENT CONFERENCE ON SEPTEMBER 10, 2009 Aug 31, 2009 REGADO BIOSCIENCES RELEASES POSITIVE PHASE 2A DATA FOR THE REVERSIBLE ANTICOAGULANT SYSTEM REG1 AT THE EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS IN BARCELONA, SPAIN Aug 24, 2009 REGADO BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 1 STUDY OF SUBCUTANEOUSLY ADMINISTERED REG1 ANTICOAGULATION SYSTEM Jul 20, 2009 REGADO BIOSCIENCES EXPANDS MEDICAL ADVISORY BOARD Jun 02, 2009 REGADO BIOSCIENCES ESTABLISHES MEDICAL ADVISORY BOARD Mar 30, 2009 REGADO BIOSCIENCES TO PRESENT AT THE 16TH ANNUAL FUTURE LEADERS IN THE BIOTECH INDUSTRY CONFERENCE Mar 17, 2009 REGADO BIOSCIENCES SELECTED TO PRESENT AT INSIDEVENTURE’S DEBUT INVESTOR CONFERENCE - MARCH 25-26, SANTA BARBARA, CALIFORNIA Feb 12, 2009 REGADO BIOSCIENCES TO PRESENT AT THE 2009 WHARTON HEALTHCARE BUSINESS CONFERENCE Jan 15, 2009 DR. STEVEN L. ZELENKOFSKE JOINS REGADO BIOSCIENCES AS SENIOR VICE PRESIDENT, CLINICAL AND MEDICAL AFFAIRS AND CHIEF MEDICAL OFFICER Jan 6, 2009 REGADO BIOSCIENCES TO PRESENT AT THE 27TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE Dec 2, 2008 ELLEN MCDONALD JOINS REGADO BIOSCIENCES AS SENIOR VICE PRESIDENT OF BUSINESS OPERATIONS AND CHIEF BUSINESS OFFICER Dec 1, 2008 REGADO BIOSCIENCES TO PRESENT AT THE PIPER JAFFRAY HEALTH CARE CONFERENCE ON TUESDAY, DECEMBER 2, 2008 Nov 11, 2008 ALEXANDER R. GIAQUINTO, PH.D., JOINS REGADO BIOSCIENCES AS SENIOR VICE PRESIDENT OF REGULATORY AFFAIRS AND QUALITY ASSURANCE Oct 14, 2008 REGADO BIOSCIENCES COMPLETES PATIENT ENROLLMENT FOR PHASE IIA STUDY OF REG1 ANTICOAGULATION SYSTEM Sep 2, 2008 REGADO BIOSCIENCES REPORTS CLINICAL RESULTS FOR REG1 ANTICOAGULATION SYSTEM AT EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2008 Aug 4, 2008 DAVID J. MAZZO, PH.D., JOINS REGADO BIOSCIENCES AS PRESIDENT AND CEO Jun 5, 2008 REGADO BIOSCIENCES ANNOUNCES PUBLICATION IN CIRCULATION OF CLINICAL TRIAL RESULTS OF REG1 ANTICOAGULATION SYSTEM May 14, 2008 REGADO BIOSCIENCES’ REG1 ANTICOAGULATION SYSTEM STUDY RESULTS PUBLISHED IN THE JOURNAL OF THROMBOSIS AND HAEMOSTASIS Nov 6, 2007 REGADO BIOSCIENCES PRESENTS PHASE I DATA FOR REG1 ANTICOAGULATION SYSTEM AT AMERICAN HEART ASSOCIATION 2007 SCIENTIFIC SESSIONS Nov 4, 2007 REGADO BIOSCIENCES PRESENTS POSITIVE DATA FROM REG1 ANTICOAGULATION SYSTEM PHASE Ic STUDY AT AMERICAN HEART ASSOCIATION 2007 SCIENTIFIC SESSIONS Mar 27, 2007 REGADO BIOSCIENCES COMPLETES $23 MILLION SERIES C FINANCING